Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Erythromycin impurity 3 is a known impurity associated with erythromycin, a macrolide antibiotic. It serves as a critical reference standard in assessing the purity and quality of erythromycin formulations. Its characterization is essential for pharmaceutical research and development to ensure compliance with regulatory standards and safety profiles in drug manufacturing. -
Drug Impurity
Estriol impurity 2, also known as 3-Methoxyestriol, is a known impurity of the steroid hormone estriol. This compound serves as a useful reference standard in the quality control of pharmaceutical formulations containing estriol. It aids in ensuring the purity and consistency of drug products by providing crucial data for analytical methods such as HPLC and chromatography. -
Drug Impurity
Candesartan impurity 13 is a known impurity associated with the antihypertensive agent Candesartan. This compound is utilized primarily in the pharmaceutical industry for ensuring the quality and safety of Candesartan formulations. Its analysis contributes to compliance with regulatory standards and aids in the development of analytical methods for impurity profiling in drug development. -
Drug Impurity
Bumetanide impurity 1 is a chemical impurity associated with the diuretic agent Bumetanide. It serves as a critical reference standard for the analysis and characterization of pharmaceutical formulations. This reagent is essential for quality control and regulatory compliance in drug development, ensuring the integrity and safety of Bumetanide-related products. -
Drug Impurity
Tamsulosin impurity 8 is a chemical impurity associated with Tamsulosin. It is important for assessing the quality and purity of pharmaceutical formulations containing Tamsulosin. This impurity may be utilized in research applications focused on drug development, stability testing, and regulatory compliance to ensure the safety and efficacy of therapeutic products. -
Drug Impurity
Tramadol impurity 1 hydrochloride is a chemical impurity associated with Tramadol hydrochloride. This compound is primarily of interest in pharmaceutical research for its implications in drug formulation and quality control. Its identification and quantification are critical for ensuring the safety and efficacy of Tramadol-containing medications. This reagent aids in the development of reliable analytical methods for detecting impurities in pharmaceutical products. -
Drug Impurity
Clopidogrel impurity 11 is a structural impurity associated with the antiplatelet drug Clopidogrel. This compound is primarily utilized in research settings to investigate the quality and stability of clopidogrel formulations. Its characterization and quantification are essential for ensuring the safety and efficacy of pharmaceutical products containing clopidogrel. -
Drug Impurity
Candesartan impurity 27, also known as Ethyl candesartan, serves as a notable impurity of the antihypertensive agent Candesartan. This compound is primarily used for research purposes, particularly in the analysis of drug formulations and quality control. Its presence can provide insights into the synthesis and stability of Candesartan, aiding in the development of more effective and safer pharmaceutical products. -
Drug Impurity
Bupropion impurity 20 is identified as a drug impurity of bupropion, primarily serving as a reference standard in analytical chemistry. Its presence is critical for assessing the purity and quality of bupropion formulations. Researchers utilize this impurity in stability studies and compliance with regulatory standards, ensuring accurate evaluations of pharmaceutical products containing bupropion. -
Drug Impurity
Olmesartan impurity 17 is a known impurity of the antihypertensive agent Olmesartan. This compound is critical for quality control and regulatory compliance in the synthesis and formulation of Olmesartan. Its characterization supports the evaluation of drug purity and safety in pharmacological studies. -
Drug Impurity
Prasugrel impurity 9 is a recognized impurity associated with the antiplatelet agent prasugrel. The compound serves as a critical reference standard for analytical chemistry, particularly in the quality control and pharmacokinetic studies of prasugrel formulations. Its characterization supports the assessment of drug purity and helps to understand the compound's stability and degradation pathways in pharmaceutical applications. -
Drug Impurity
Telmisartan impurity 15 is a drug impurity associated with Telmisartan, an antihypertensive agent that selectively inhibits the angiotensin II receptor. This impurity plays a critical role in analytical chemistry, providing a standard for the assessment of pharmaceutical purity and stability in drug formulation studies. It may be utilized in methods such as HPLC for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Aripiprazole impurity 12 is a recognized impurity of the antipsychotic agent Aripiprazole. This compound serves as an important reference standard for the analysis of drug purity and identification in pharmaceutical research. Its characterization and quantification are essential for regulatory compliance and quality control during the development and manufacturing of Aripiprazole-containing formulations. -
Drug Impurity
Aripiprazole impurity 2 is a known impurity of the antipsychotic agent Aripiprazole. This compound is often utilized in quality control and analytical studies to ensure the purity and safety of pharmaceutical formulations. Its analysis is critical for regulatory compliance and the development of robust analytical methods in drug research. -
Drug Impurity
Afatinib impurity 102 is a characterized impurity associated with Afatinib, a potent irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity is primarily utilized in pharmaceutical research to ensure the quality and purity of Afatinib formulations. Its analysis supports compliance and validation processes in drug development and quality control. -
Drug Impurity
Tenofovir impurity 12 is a recognized impurity associated with Tenofovir, an antiviral medication. This compound is essential for quality control in the synthesis of Tenofovir, allowing researchers to identify and quantify impurities that may impact drug efficacy and safety. Its characterization is crucial for compliance with regulatory standards in pharmaceutical development and formulation analysis. -
Drug Impurity
Metoprolol impurity 8 is a known impurity of Metoprolol, primarily utilized in drug characterization and quality control studies. Its presence can influence the stability and efficacy of pharmaceutical formulations. This reagent is valuable for researchers conducting analytical assessments and method validation in the synthesis and evaluation of beta-blocker drugs. -
Drug Impurity
Carvedilol impurity 14 is a chemical impurity related to the cardiac medication Carvedilol. This compound is utilized primarily in analytical research aimed at assessing the purity of pharmaceutical formulations. Its characterization is essential for quality control in the development and manufacturing processes of Carvedilol-based products. -
Drug Impurity
Aripiprazole impurity 32, also known as Deschloroaripiprazole, is a chemical impurity associated with the antipsychotic agent Aripiprazole. This impurity is important for analytical characterization in pharmaceutical research and development, particularly in the assessment of drug purity and stability. Its presence can significantly impact the pharmacological profile and safety evaluation of Aripiprazole formulations. Therefore, it is essential in quality control processes within drug development and regulatory compliance. -
Drug Impurity
Haloperidol impurity 11 is a known impurity of the antipsychotic agent Haloperidol. Its chemical characterization is crucial for quality control in pharmaceutical formulations. This impurity can serve as a reference standard in analytical studies aimed at ensuring the purity and efficacy of Haloperidol-based medications. Research applications include stability testing, formulation development, and regulatory compliance assessments. -
Drug Impurity
Irinotecan impurity 52 is a significant impurity associated with Irinotecan, a chemotherapeutic agent targeting topoisomerase I. This compound is used in drug development and quality control to assess the purity of Irinotecan formulations. Its identification and quantification are crucial for ensuring the safety and efficacy of cancer treatment regimens involving Irinotecan. -
Drug Impurity
Tenofovir impurity 2, also known as (S)-Tenofovir disoproxil, serves as a chemical impurity of the antiviral drug Tenofovir. This compound is crucial for analytical and quality control applications in pharmaceutical research, particularly in the assessment of Tenofovir's purity. Its presence is important for understanding the overall safety and efficacy profiles of Tenofovir-based formulations. -
Drug Impurity
Ropinirole impurity 7, also known as SKF-96266, is a chemical impurity associated with the synthesis of Ropinirole. This compound serves as an analytical standard for quality control in pharmaceutical development, facilitating the detection and quantification of Ropinirole impurities. Its characterization is critical for ensuring the purity and safety of Ropinirole in clinical applications. -
Drug Impurity
Haloperidol impurity 12 is a known impurity associated with the antipsychotic agent Haloperidol, primarily identified through analytical methods in pharmaceutical research. This compound serves as a reference standard for the evaluation of drug purity and quality control in the synthesis of Haloperidol. Its characterization is essential for ensuring the safety and efficacy of Haloperidol formulations in clinical applications. -
Drug Impurity
Etoricoxib impurity 10 is identified as a significant impurity of the nonsteroidal anti-inflammatory drug Etoricoxib. This compound is utilized primarily in pharmaceutical research to assess the purity and quality of Etoricoxib formulations. Its presence can impact the safety and efficacy profile of drug products, making it relevant for regulatory compliance and analytical chemistry studies. -
Drug Impurity
Rosuvastatin impurity 44, also known as Rosuvastatin-Lactone Impurity, is a chemical entity related to the statin class of drugs, specifically acting as an impurity of Rosuvastatin. Its presence can have implications for drug quality and efficacy. This compound is essential for quality control and analytical studies in pharmaceutical research, particularly in the evaluation of Rosuvastatin formulations. -
Drug Impurity
Tenofovir impurity 5 is a degradation product of Tenofovir, a nucleoside reverse transcriptase inhibitor. This compound serves as an important reference standard in pharmaceutical development for assessing the purity and stability of Tenofovir formulations. It is essential for quality control and compliance in the manufacturing of antiretroviral drugs. -
Drug Impurity
Acebutolol impurity 2 is a known impurity associated with the beta-adrenergic antagonist Acebutolol. This compound is utilized primarily in pharmaceutical research to assess the purity and stability of Acebutolol formulations. Its identification and quantification are crucial for ensuring the safety and efficacy of beta-blocker therapies in clinical applications. -
Drug Impurity
Carvedilol impurity 4 is a known impurity of the beta-blocker carvedilol, primarily utilized in the assessment of drug quality and safety. This compound is relevant in pharmaceutical research and development, particularly in studies focusing on the characterization of drug formulations and the evaluation of potential effects of impurities on pharmacological activity. Its presence is critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Progesterone impurity 6, also known as 1-Dehydroprogesterone, is a chemical impurity associated with Progesterone synthesis. This compound may serve as a useful reference standard for the characterization and quantification of progesterone and its derivatives in pharmaceutical formulations. Its presence can influence drug activity and stability, making it relevant in studies concerning drug formulation and quality control. -
Drug Impurity
Tamsulosin impurity 4 is a known impurity associated with the pharmaceutical compound Tamsulosin. This chemical entity is primarily utilized in the assessment of drug purity and quality control in pharmaceutical research and development. Its presence is critical for ensuring compliance with regulatory standards in medication formulation, contributing to the overall safety and efficacy of Tamsulosin-based therapeutics. -
Drug Impurity
Sildenafil impurity 6 is a characterized impurity of Sildenafil, primarily utilized in purity assessment during drug development. This impurity serves as a critical reference standard for analytical studies, supporting quality control and compliance in pharmaceutical research. Its presence can influence the pharmacokinetic and pharmacodynamic profiles of the parent compound, making it an important focus in the evaluation of Sildenafil formulations. -
Drug Impurity
Paliperidone impurity 6, also known as 9-Keto risperidone, is a known impurity of the antipsychotic drug paliperidone. This compound may serve as a valuable reference standard for evaluating the purity and quality of paliperidone formulations. Its identification is important for ensuring the safety and efficacy of pharmaceutical products containing paliperidone in clinical and research settings. -
Drug Impurity
Haloperidol impurity 15, also known as Haloperidol Undecanoate, is a chemical impurity associated with Haloperidol. This compound is primarily studied for its role in assessing the purity of Haloperidol formulations. It serves as an essential tool in drug quality control and pharmacological research, facilitating comprehensive investigations into the effects of Haloperidol and its metabolites. -
Drug Impurity
Ramipril impurity 2 (ent-Ramipril) is a known impurity of the angiotensin-converting enzyme (ACE) inhibitor Ramipril. This compound is utilized primarily in drug characterization and quality control studies to assess the purity and stability of pharmaceutical preparations. Understanding this impurity is essential for ensuring the safety and efficacy of Ramipril and its formulations in clinical applications. -
Drug Impurity
Methylprednisolone acetate impurity 4 is a known impurity associated with the synthesis of Methylprednisolone acetate, a synthetic corticosteroid. This compound is relevant in the context of drug quality control and stability studies, assisting researchers in evaluating the purity of pharmaceutical formulations. Its analysis is critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Tenofovir impurity 24 is a chemical impurity associated with the antiviral drug Tenofovir. It is primarily utilized in pharmaceutical research and quality control to assess the purity of Tenofovir formulations. The presence of such impurities is critical for ensuring drug safety, efficacy, and regulatory compliance. -
Drug Impurity
Quetiapine impurity 2, also known as Quetiapine carboxylate impurity, is a chemical impurity associated with the antipsychotic agent Quetiapine. This compound can serve as a critical reference standard in the analysis of pharmaceutical formulations, ensuring the purity and compliance of drug products. Its study is essential for understanding the implications of impurities on drug efficacy and safety in pharmaceutical research. -
Drug Impurity
Leflunomide impurity 8 is identified as 5-Methyl-N-(p-tolyl)isoxazole-4-carboxamide and serves as a drug impurity. This compound may be utilized in pharmacological studies and analytical chemistry to assess the purity and quality of leflunomide formulations. Its presence can impact the evaluation of drug safety and efficacy, making it a significant marker in drug development and quality control processes. -
Drug Impurity
Glipizide impurity 2, also known as Glipizide impurity A, is a known impurity associated with the antidiabetic agent Glipizide. This compound is essential for analytical development and quality control in pharmaceutical research, helping to ensure the purity and safety of Glipizide formulations. Its identification and quantification are critical in compliance with regulatory standards for drug manufacturing. -
Drug Impurity
Paliperidone impurity 11 is a defluorinated derivative of Paliperidone, serving as a key impurity in drug synthesis and quality control. This compound is utilized in the assessment of Paliperidone formulations to ensure compliance with pharmaceutical standards and regulations. Its characterization is essential in understanding the stability, efficacy, and safety of the final pharmaceutical product. -
Drug Impurity
Sildenafil Impurity 3 is a chemical byproduct associated with the phosphodiesterase type 5 (PDE5) inhibitor sildenafil. This impurity is crucial for quality control and safety assessments in pharmaceutical formulations of sildenafil. It serves as a reference standard in analytical chemistry for identifying and quantifying impurities during the development and testing of PDE5 inhibitors, ensuring regulatory compliance and product integrity. -
Drug Impurity
Clindamycin phosphate impurity 8 is a known impurity of clindamycin phosphate, affecting the overall quality and efficacy of formulations containing this antibiotic. Its presence can influence pharmacokinetics and pharmacodynamics, making it important in stability studies and quality control assessments. This compound is primarily utilized in the analysis of clindamycin phosphate formulations in pharmaceutical research and development. -
Drug Impurity
Azilsartan Impurity 30, also known as Azilsartan-13, is a chemical impurity associated with the antihypertensive agent Azilsartan. This compound is utilized primarily for analytical and quality control purposes in pharmaceutical research. It provides insight into the purity of Azilsartan and assists in the evaluation of formulation stability and efficacy. -
Drug Impurity
Testosterone impurity 6 is a notable impurity associated with Testosterone. This compound is critical for analytical studies in pharmaceutical research, particularly in the evaluation of drug purity and stability. Its presence can impact pharmacokinetic profiles and may influence the overall safety and efficacy of testosterone-derived therapies. Testing for this impurity is essential for ensuring compliance with regulatory standards in the development of hormone-related medications. -
Drug Impurity
Chlorthalidone impurity 4 is a known impurity associated with the thiazide diuretic chlorthalidone. It plays a significant role in pharmaceutical analysis, particularly in the assessment of drug quality and purity. This compound is utilized in regulatory settings to ensure compliance with guidelines for impurity levels in therapeutic formulations. Its characterization aids in understanding the stability and safety profiles of chlorthalidone-based medications. -
Drug Impurity
Everolimus impurity 16 is a known impurity of the mTOR inhibitor Everolimus. It is essential for analytical and quality control studies, particularly in the evaluation of Everolimus formulations. This compound can be used to assess the purity and stability of pharmaceutical preparations, providing crucial data for drug development and regulatory compliance. -
Drug Impurity
Abacavir impurity 9 is a drug impurity associated with Abacavir, an antiretroviral medication used in the treatment of HIV. This compound is important for quality control and analytical studies in pharmaceutical research, assisting in understanding the stability and degradation pathways of Abacavir. Its characterization is crucial for ensuring the safety and efficacy of formulations containing Abacavir. -
Drug Impurity
Allopurinol impurity 5 is a chemical impurity associated with the synthesis of Allopurinol, which primarily targets xanthine oxidase. This impurity can be utilized in pharmacokinetic and toxicological studies to assess the purity of Allopurinol formulations. Its analysis is critical for ensuring the quality and safety of pharmaceutical products containing Allopurinol. -
Drug Impurity
Buspirone Impurity 10 is a identified impurity of the anxiolytic compound buspirone, primarily associated with its synthesis and analytical evaluation. This compound serves as a reference standard for the characterization and quantification of impurities in pharmaceutical formulations. It is valuable for quality control and regulatory compliance in drug development and production processes.
